Most biological actions of prostaglandins and thromboxane A2 are thought to be mediated by alterations of tissue cyclic nucleotide concentrations. We have shown that endogenous prostaglandins regulate basal and homone-stimulated cyclic AMP concentrations in cultured renal tubular cells retaining and homone-stimulated cyclic AMP concentrations in cultured renal tubular cells retaining differentiated properties. In short-term (2 min) incubations endogenous prostaglandins appeared to be 5 to 10 times more effective than exogenous prostaglandins in increasing intracellulr cyclic AMP concentrations. We have also shown that cyclic AMP and its analogs inhibit prostaglandin biosynthesis by decreasing acylhdrolase (phospholipase) and fatty acid cyclo-oxygenase activity. This applicant proposes to identify the specific endogenous prostaglandins which regulate cyclic AMP concentrations and the reasons for the increased efficacy of endogenous relative to exogenous prostaglandins in cultured renal tubular (MDCK), aortic endothelial and smooth mcuscle cells. Emphasis in aortic cultures, will be placed on prostacyclin (prostaglandin I(2)), a potent vasodilator and anti-thrombotic agent. The regulation of cyclic AMP and cyclic GMP concentrations in the aforementioned cultured cells by platelet-derived arachidonate metabolites, namely thromboxane A(2) and 12-hydroperoxy-5,8,10,14-eicosatetraenoic acid will also be investigated. I also propose to investigate, in detail, the mechanism by which cAMP may inhibit acylhydrolase activity by determining cAMP-induced changes of phospholipid and particularly, of phosphatidylinositol metabolism as well as the cAMP-induced changes of cyclo-oxygenase activity. The potential for cyclic GMP to stimulate prostaglandin biosynthesis will also be investigated. Among the many biochemical methods which will be used are radioimmunoassay of prostaglandins and cyclic nucleotides, as well as radiometric thin-layer chromatography of prostaglandins and phospholipids. Increased understanding of prostaglandin-cyclic nucleotide interactions in renal and vascular cells will be of potential benefit to our understanding of renal water and salt metabolism, regulation of vascular tone, thrombosis, and athersclerosis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL034304-01
Application #
3347077
Study Section
Experimental Cardiovascular Sciences Study Section (ECS)
Project Start
1985-01-01
Project End
1987-12-31
Budget Start
1985-01-01
Budget End
1985-12-31
Support Year
1
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Tennessee Health Science Center
Department
Type
Schools of Medicine
DUNS #
941884009
City
Memphis
State
TN
Country
United States
Zip Code
38163
Ghomashchi, F; Stewart, A; Hefner, Y et al. (2001) A pyrrolidine-based specific inhibitor of cytosolic phospholipase A(2)alpha blocks arachidonic acid release in a variety of mammalian cells. Biochim Biophys Acta 1513:160-6
Voelkel, N F; Czartolomna, J; Simpson, J et al. (1992) FMLP causes eicosanoid-dependent vasoconstriction and edema in lungs from endotoxin-primed rats. Am Rev Respir Dis 145:701-11
Garg, U C; Hassid, A (1989) Inhibition of rat mesangial cell mitogenesis by nitric oxide-generating vasodilators. Am J Physiol 257:F60-6
Garg, U C; Hassid, A (1989) Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83:1774-7
Hassid, A; Yu, Y M (1989) Mechanism of atriopeptin-induced decrease of cytosolic free Ca in rat vascular smooth muscle cells: evidence for an intracellular locus of action. J Cardiovasc Pharmacol 14 Suppl 6:S34-8
Johnson, A; Lermioglu, F; Garg, U C et al. (1988) A novel biological effect of atrial natriuretic hormone: inhibition of mesangial cell mitogenesis. Biochem Biophys Res Commun 152:893-7
Morgan-Boyd, R; Stewart, J M; Vavrek, R J et al. (1987) Effects of bradykinin and angiotensin II on intracellular Ca2+ dynamics in endothelial cells. Am J Physiol 253:C588-98
Crowley, W R; Hassid, A; Kalra, S P (1987) Neuropeptide Y enhances the release of luteinizing hormone (LH) induced by LH-releasing hormone. Endocrinology 120:941-5
Erman, A; Hassid, A; Baer, P G et al. (1986) Treatment with dexamethasone increases glomerular prostaglandin synthesis in rats. J Pharmacol Exp Ther 239:296-301
Hassid, A (1986) Increase of cyclic AMP concentrations in cultured vascular smooth muscle cells by vasoactive peptide hormones. Role of endogenous prostaglandins. J Pharmacol Exp Ther 239:334-9